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Abstract
The Mediterranean diet (MD) emerged as a healthy food regimen long before it could be recognised which nutrients or foods were
responsible for its observed benefits, and it was only in the middle of the last century that the first scientific approach ‘The Seven Countries
Study’ appeared. Epidemiological and anthropological studies of the MD converged, first by investigating at single nutrients or foods, then
by adopting the more holistic approach of dietary patterns (DP), and now with a molecular approach. These studies resulted in convincing
evidence that a MD decreases the risk of all-cause mortality and cardiovascular mortality and incidence. A risk reduction of developing type
2 diabetes is probable. Evidence is less stringent for other metabolic diseases and all cancers but from possible to probable for some cancer
sites. Although DP showed that the MD has to be considered in its totality, olive oil could have a specific role. Lifestyle factors such as
physical activity for energy balance, outdoor life for vitamin D synthesis and conviviality are also probably partly responsible for the
health benefits. The MD is a lifestyle well suited for coping not only with personal health but also with wider societal concerns in relation
to environment, public health and economy.
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The Mediterranean diet (MD) emerged as a healthy food
regimen long before it could be recognised which nutrients,
or indeed which foods, were responsible for its observed
benefits. From the rich picture that anthropologists pro-
vided from various Mediterranean countries, biologists and
epidemiologists embarked on a long path towards a full
understanding of the aetiology of the observed health ben-
efits, first by investigating at single nutrients or foods, then
by adopting a more holistic dietary pattern (DP) approach,
and this is now being completed with a molecular under-
standing. Although health and science have always been
associated with studies of the MD, other characteristics such
as environmental and public health concerns are also import-
ant. The present study briefly considers the history of the
emergence of the MD as a healthy DP, and this is followed
by recent biological and epidemiological evidence for
its stronger health benefits, before concluding with a brief
discussion of its societal relevance.
Historical context
The MD was already characterised by the time of ancient
Egyptian civilisation as illustrated by a sculpture on the
tomb of Ramses II showing the association of cereals, olive
trees and vine. However, it was Castelvetro(1), an Italian
exiled in England, who in 1634 first mentioned its relationship
with health when, complaining about the local population
eating too much meat and not enough fruit and vegetables,
he praised the MD for a better health. Much later, in the
second part of the twentieth century, the Rockefeller Foun-
dation came to Greece and made an unexpected observation:
‘a people with good health and impressive longevity living
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in a country deprived of the modern developments present in
the US, and eating vegetables floating in oil(2)!’
But it was 10 years later before a scientific approach
emerged on the effects of the MD, when in the 1960s Keys
et al.(3) initiated a large ecological study, the Seven Countries
Study, with sixteen cohorts in Mediterranean and non-
Mediterranean countries. This showed for the first time the
low mortality rates in countries around the North shore of
the Mediterranean (especially Crete). About 10 years later,
the (Multinational MONItoring of trends and determinants
in CArdiovascular disease) MONICA study was undertaken
in Europe with CVD incidence as an end point (this is more
relevant than mortality)(4). Lower rates of CHD were observed
in Spain and Southern France compared with Northern France
and North European countries. In both studies, the Seven
Countries Study and MONICA, dietary questionnaires were
collected in subgroups of the cohorts and the main food
groups typical of the MD were identified. These studies
noted that in many regions on the North shores of the Medi-
terranean, people were eating the same types of food, even
though recipes were different. These consisted of plenty of
plant foods including whole grain cereals as staple food, veg-
etables and fruits (fresh or dried) eaten either raw or cooked.
Legumes (lentils, chickpeas and beans), nuts (almonds, pista-
chios, hazelnuts and walnuts), herbs (thyme, rosemary and
basil) and spices (nutmeg, cinnamon and saffron) were also
consumed. Fish and seafood were frequent in meals, even
in rural areas distant from the sea as they were dried or
salted. Meat was only present in a few meals, generally for
fiestas, and lamb was preferred. Dairy products were also con-
sumed in moderation, often as fresh cheese from the milk of
ewes or goats. Even though staple foods (rice, polenta, bul-
ghur or bread), cooking practices, choice of fruits and veg-
etables, and use of wild herbs were different, there were
two common denominators in the diets of Northern Mediterra-
nean countries: olive oil and wine. Olive oil was used in all
meals for cooking and salad dressings and wine was regularly
drunk with meals in moderate amounts. Thus, nutritionists ela-
borated the MD model from these comprehensive obser-
vations of the traditional food habits (Table 1).
Biology
Fatty acids
The quality of fatty acids is an important nutritional factor in
disease prevention, and it was Keys et al.(3) who first pro-
posed that the ratio of MUFA:SFA was the key component
for the health benefits of the MD. Then, after the Lyon Diet
Heart Study, a-linolenic acid appeared as important for the
prevention of post-myocardial infarct death(5). This was
explained by the observation that a-linolenic acid, when pre-
sent in sufficient amounts, is an efficient precursor of EPA, and
it is EPA that is responsible for the observed benefits(6). Thus,
long-chain n-3 fatty acids, together with their metabolites
(anti-inflammatory leukotrienes), were reported as essential
for the prevention of CVD.
More recently, the importance of the SFA carbon chain
length was evoked. Whereas C12 to C16 SFA are known
to be atherogenic, SFA with a medium carbon chain length
(caproic C6, caprylic C8 and capric C10) are directly
b-oxidised in the liver and so are less atherogenic. Caprylic
acid is also an inhibitor of the apoB(7). This is relevant to
the health benefits of the traditional MD, as these fatty acids
are in higher concentrations in goats and sheep – the main
sources of meat and milk in the MD – than in cows(8).
Phenolics
Due to the rich diversity of plant foods in the MD, there is a high
and varied intake of phenolic compounds, including
flavonoids and various non-flavonoids such as phenolic acids,
stilbenes and lignans. Total polyphenol intake by the Preven-
cio´n con Dieta Mediterra´nea (PREDIMED) cohort was recently
estimated at 820 (SD 323)mg/d, with coffee, fruits, olive oil and
wine being the major sources(9). The importance of phenolics
for the cardiovascular benefits of extra virgin olive oil (EVOO)
has been shown by comparing olive oils that are high and low
in phenolics. For example, olive oil increased HDL-cholesterol
level and lowered oxidised LDL-cholesterol level in proportion
to the phenolic content of the oil(10), and the European Food
Safety Authority has now recognised the importance of olive
oil polyphenols for protecting LDL particles from oxidative
damage. Phenolics in wine may also help protect individuals
against CVD by contributing to the overall antioxidant
effects of the MD, especially when the body is under conditions
of oxidative stress that occurs after a meal(11).
Although in vitro studies identified phenolics as direct
antioxidants, other more likely in vivo targets are now being
identified. These include increasing phase II enzymes in
order to eliminate xenobiotics such as carcinogens, by repres-
sing molecules involved in proliferation (such as protein
kinase C (PKC), c-Jun and c-Fos), and by inducing apoptosis
(caspases). Inhibition by phenolics of the pro-inflammatory
transcription factor nuclear factor-kB (NF-kB), the pro-oxidant
transcription factor activator protein 1 (AP-1), and activation of
the antioxidant transcription factor NFE2-related factor 2
(Nrf2) may be involved in reducing oxidative stress and low-
grade chronic inflammation and may contribute to the wide
ranging benefits of phenolics against chronic diseases(12,13).
Consumption of polyphenol-rich olive oil as part of a MD
has also been shown to decrease the expression of a
number of genes associated with oxidative stress and inflam-
mation(14). Phenolics generally have low bioavailability and
low concentrations in the systemic circulation, and this tends
Table 1. The components of the Mediterranean diet
Cereals (whole grain)
Plenty of vegetables and fruits (raw, cooked or dried) and nuts
Legumes (chickpeas, lentils and beans)
Herbs and spices
Fish and seafood (fresh, dried and pickled)
Moderate amounts of meat and dairy products, preferably from small
ruminants (goats and sheep)
Olive oil for salad dressing and cooking
Moderate amounts of wine with meals
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to confirm that direct antioxidant activity is not their main
mechanism of action in vivo (15).
A group of phenolics known as secoiridoids (such as
oleuropein) and their breakdown products (such as hydroxy-
tyrosol) are found almost exclusively in olives and olive oil
and so are of particular interest in relation to observations
that EVOO may confer specific benefits as part of a MD
(discussed below). One recently reported target for EVOO
secoiridoids (and also resveratrol in red wine) is activation
of the energy-sensing enzyme AMP-activated protein
kinase(16). AMP-activated protein kinase is currently attracting
a good deal of attention as it switches on catabolic pathways,
such as increased uptake and oxidation of glucose and fatty
acids, and this is implicated in decreasing the risk for obesity,
type 2 diabetes and some cancers.
More disease-specific mechanisms for phenolics have also
been reported including reduced plaque formation by
oleuropein aglycone in a mouse model for Alzheimer’s
disease(17) and anti-diabetic and anti-cancer effects by
flavonoids(18,19). Polyphenols in EVOO promote the proteasomal
degradation of human epidermal growth factor receptor 2
(HER2)(20), although it has not been established if this is associ-
ated with beneficial effects in HER2 þ breast cancer. Olive oil
(both virgin and non-virgin) was also identified as the major diet-
ary source of lignans in the PREDIMED cohort(9). Lignans act as
phyto-oestrogens in the body and were reported to be associated
with a reduced risk of breast cancer in post-menopausal women,
although it is unclear if additional anti-cancer mechanisms may
also be involved(21).
There is now an increased understanding of how crosstalk
between phenolics and other nutrients may contribute
to disease prevention(22), and this is helping to provide a
mechanistic basis for explaining the epidemiological evidence
which suggests that it is the overall MD that is most important
for its benefits. This is discussed in the next section.
Epidemiology
Science: the holistic approach
After the historical studies described above, the Harvard group
listed the beneficial foods of the MD and those which were
either absent or consumed in moderation(23,24). But the
health benefits of individual nutrients or foods were never
completely convincing; it is the holistic approach that best
captures the evidence(25).
Different epidemiological designs can be used in this holis-
tic perspective: DP and intervention studies using a nutritional
approach. Two techniques are commonly implemented to
study the relationship between DP and diseases. A posteriori
analysis is a principal component analysis that defines DP in
a population. These analyses are transformed into summary
scores that can be analysed by regression analysis in order
to examine the risk of a disease related to the identified pat-
terns. This technique gives information on the effects of a
MD only if a sample of the population follows this model.
In the a priori model, a predefined score is applied to the
nutritional data of a population. With regard to the MD, the
Mediterranean diet score (MDS) of Trichopoulou first
described in 1995(26), and completed and finalised in 2003
by the introduction of fish intake(27), has been used most
often. However, it is apparent that the Trichopoulou score,
including the quantitatively and qualitatively typical MD of
the elderly Greeks, was until recently only appropriate for
Mediterranean populations, because (1) in the Greek situation,
the MUFA:SFA ratio reflects mainly the consumption of olive
oil, which is not the case for North European countries or
the USA; (2) the median defining fruit and vegetable con-
sumption in the elderly Greek population (vegetables
$500 g/d, fruits $350 g/d) is not commonly attained in
North European countries or in the USA and therefore the
MDS based on the median consumption of these North
European countries or the USA may not show a benefit of
MD as it did not reflect the typical quantitative characteristics
of the MD. Thus, several modifications have been published
that adapt the MDS to diverse populations, and in these
cases, the health benefits are generally lower than those
observed in Mediterranean countries (for a complete evalua-
tion of DP and MD, see Hoffman & Gerber(28)).
A few intervention studies(29–32) have implemented a nutri-
tional approach to study the effects of a MD on markers of risk
for CVD, with advice for a MD in the experimental group, and
either a high intake of SFA, or a prudent diet or an American
Heart Association diet as a control group. However, only
PREDIMED(31) had a sample large enough and a follow-up
that allowed CVD incidence and mortality to be recorded.
The results of these recent approaches constitute a body of
studies with convincing levels of evidence with regard to
some health effects, namely all-cause mortality and cardiovas-
cular mortality. They also highlight areas requiring further
investigation, such as the specific effects of olive oil.
Health: assessing the evidence
The inference of causality has been a long search for epide-
miologists and was initiated by Hill(33). The World Cancer
Research Fund(34) has established criteria for levels of evi-
dence very close to Hill’s proposal, with the improvement of
introducing a hierarchy for assessing the validity of the designs
of the studies, with intervention studies and prospective
studies placed at the top. Meta-analyses are also of value as
long as they include evaluation of heterogeneity, sensitivity
and linear response analysis. An intervention study conducted
on a representative population brings results that are the
closest to demonstrating a causal relationship between an
exposure and health. Consistent results of several prospective
studies conducted in different populations in different
countries also provide a strong level of evidence. Thus, the
only studies presented here are those for which there is
enough data to support a conclusion with a convincing or
probable level of evidence for a relationship with the MD.
Mediterranean diet
Results are convincing with regard to the effect of a MD on
all-cause mortality as illustrated by the meta-analysis of Sofi
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et al.(35) and further supported by the latest results from the
Women’s Health Initiative (WHI) study(36) and the Seguimiento
Universidad de Navarra (SUN) study(37). Further evidence
comes from the Nurses’ Health Study and Health Professionals
Follow-Up Study(35), although these cohorts had CVD at the
beginning of the study(38). The risk reduction is always greater
in Mediterranean countries (by 20–30%) and always greater for
cardiovascular mortality than for cancers, as shown in Table 2
for studies that have evaluated both all-cause and cause-specific
mortalities(27,39,40). Table 2 also shows the remarkable consistency
between different studies and populations for the hazard ratio for
all-cause mortality and cardiovascular mortality.
The PREDIMED intervention study best supports a risk
reduction effect of the MD on CVD incidence. It has an inter-
esting peculiarity in that there were two experimental groups:
one enriched in nuts and the other enriched in EVOO. The
control group consumed a low-fat American Heart Association
type diet. Compared with the control group, there was a 28 %
(95 % CI 0·54, 0·96) risk reduction in the nut-enriched group
and a 30 % (95 % CI 0·54, 0·92) risk reduction in the EVOO-
enriched group after 5 years of follow-up(31). Total mortality
over 5 years (Kaplan–Meier) gave a hazard ratio of 0·81
(95 % CI 0·63, 1·05; Ptrend¼ 0·11) for the EVOO group and
0·95 (95 % CI 0·73, 1·23; Ptrend¼ 0·68) for the nut group,
suggesting an advantage for olive oil consumption(31).
Thus, there is a convincing causal relationship between
a DP similar to the traditional MD and overall mortality, and
cardiovascular mortality and incidence.
The relationship between type 2 diabetes and the MD has
progressed since two early Spanish publications(41,42) and is
now supported by the latest results of the PREDIMED
study(43), and by two meta-analyses(44,45). Both meta-analyses
concluded that there was a benefit provided by MD in redu-
cing the development of type 2 diabetes (0·81, 95 % CI 0·73,
0·90 and 0·77, 95 % CI 0·66, 0·89, respectively). Both analyses
had significant heterogeneity, which was explained by either
differences in the lengths of follow-up: the longer the
length, the larger the risk reduction(45); or in the health
status of the cohort(44): studies conducted on a cohort at
CVD or diabetes risk showed the highest risk reduction.
Both analyses observed that the risk reduction was non-
significant in the US studies and significant in European
countries, further suggesting greater benefits in Mediterranean
countries, and the authors evoked the possible effects of other
beneficial factors present in the Mediterranean lifestyle not
revealed by the MDS(28).
Thus, the level of evidence for a risk reduction of type 2
diabetes development is probable.
An interesting question remains to be elucidated: Which
factors present in Mediterranean countries, in addition to the
diet, are responsible for this beneficial effect?
Effects on cancer incidence are more difficult to elucidate
since the best data come from observational prospective
studies because of practical and ethical difficulties with inter-
vention studies. Moreover, not only is each cancer type related
to different etiological factors but even within a class of cancer
there are different characteristics with regard to the risk fac-
tors, e.g. breast cancers with or without oestrogen receptors
(ER). Several studies have found inverse associations between
increasing MDS and cancer risk. These include studies that
did not include olive oil in the score such as head and
neck cancers(46), hepatocellular carcinoma(47) and gastric
cancer(48) and other studies such as for gastric cancer and
bladder cancer in smokers, which were analysed with the rela-
tive MDS in which olive oil consumption was assessed(49,50).
For breast cancer, a risk reduction was observed only
when olive oil was present as a single food(51), or using an
a posteriori DP including olive oil(52) or when using a MDS
applied to a Mediterranean population(53), but not when
applied to a non-Mediterranean population(54).
Thus, it is probable that a MD is inversely associated with
some cancers.
Table 2. Association (fully adjusted Cox hazard ratio (HR)) between Mediterranean diet scores and all-cause mortality and cause-specific mortality
(Hazard ratios and 95% confidence intervals)
Mortality by cause
Study description All cause CHD Cancer
Authors Population Adherence score HR 95% CI HR 95% CI HR 95% CI
Trichopoulou
et al.(27)
EPIC – Greece. 22 043 subjects
aged 20–90 years; 275 deaths
MDS 0·75 0·64, 0·87 0·67 0·47, 0·94 0·76 0·59, 0·98
Knoops
et al.(40)
The HALE project. 2839 North
Europeans and Italians
aged 70–90 years; 935 deaths
MDS (corrected for
8368 kJ/d
(2000 kcal/d) for
women and
10460 kJ/d (2500 kcal/d)
for men)
0·77 0·68, 0·88 0·61 0·43, 0·88 0·90 0·70, 1·17
Buckland
et al.(39)
EPIC – Spain. 40 622 subjects
aged 29–69 years; 1855 deaths
rMDS (adjusted for g
of food/8368 kJ,
and olive oil instead
of MUFA/SFA)
0·79 0·69, 0·91 0·66* 0·49, 0·89 0·92 0·75, 1·12
0·79† 0·61, 1·01
EPIC, European Prospective Investigation into Cancer and Nutrition; HALE, Healthy Ageing: a Longitudinal study in Europe; MDS, Mediterranean diet score; rMDS, relative
Mediterranean diet score.
* CVD.
†Restricted to digestive, breast and prostate.
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As for diabetes, the heterogeneity observed between Medi-
terranean and non-Mediterranean countries may possibly be
explained by factors of the global Mediterranean lifestyle,
such as physical activity, high vitamin D synthesis and quality
of life, that correlate with the diet in Mediterranean countries.
Olive oil
Although studies are sparse and further studies are required, it
is interesting to note that EVOO might have specific effects on
some diseases. This is suggested in the PREDIMED inter-
vention study, especially with regard to cardiovascular
mortality(31). In a study conducted in Spain, there was a
reduction of CVD incidence of 7 % for each increase of 10 g
of olive oil intake per 8368 kJ (2000 kcal) ingested, especially
with EVOO (risk reduction 14 %)(55). In another study on the
same population, an intake $29·4 g of olive oil/8368 kJ per
d compared with ,14·9 g of olive oil/8368 kJ per d decreased
the risk of overall mortality by 26 % (Ptrend,0·001) and
of CVD deaths by 44 % (Ptrend,001)
(56). In the European
Prospective Investigation into Cancer and Nutrition (EPIC)
Greek cohort, olive oil was associated with a risk reduction
of cerebrovascular disease incidence(57). In the latest report
on diabetes and the PREDIMED subcohort(43), the group
treated with a MD enriched with EVOO had the lowest
incidence of diabetes, and a significantly decreased RR
compared with the group on the control diet (0·60; 95 % CI
0·43, 0·85). Investigating the effects of olive oil on breast
cancer incidence in the Mediterranean cohorts of EPIC, a
risk reduction was observed for ER 2 breast cancers, although
the small number of these cancers did not allow for statistical
significance(58). In the Three Cities Study, olive oil was associ-
ated with a decrease in cognitive impairment(59).
Thus, there is some suggestion for a specific role of olive
oil in the MD, but further studies towards understanding
the precise effects of olive oil and of its specific phenolics
are required.
Societal relevance
Public health
For a long time, the high lipid content of the MD has created
opposition. Lipids represent 37–38 % of the total energy intake
in published studies on the MD, which is slightly above the
upper limit of 35 % proposed by the Food and Agriculture
Organisation (FAO)(60), and almost at the limit of 35–40 % pro-
posed by the French Food Safety Agency(61). Indeed, a MD
might be a way to reduce the public health problem of
obesity as (1) the glycaemic indices of most of foods (whole
grain cereals, vegetables and fruits) in the MD are low, and
the glycaemic load of the MD is decreased by the structure
of the Mediterranean meal; (2) a high MDS reduces the
risk of weight gain with increasing age as shown in the
longitudinal SUN study(62); (3) a traditional MD is the best
diet for maintaining a healthy weight after a regimen of
weight loss(63).
Health economics
Stroke is a frequent event in people at cardiovascular risk and,
in addition to the human suffering it causes, it is an increasing
burden on health budgets due to the increasing longevity of
European populations. In France, the mean cost of treating
a stroke is e17 000, and the total cost to France is e5·3 billion.
In 2006, annual direct health care costs associated with CHD
were estimated at £3·2 billion in the UK, and the overall cost
to the UK economy was nearly £9 billion(64). Increased
longevity is also accompanied by an increased risk of other
degenerative diseases (such as Parkinson’s and Alzheimer’s
diseases), and some studies have shown a risk reduction
for these diseases in people adhering to a MD(65,66). Thus,
prevention using a MD will save public money.
Environment
The moderate amounts of meat consumed as part of a
MD means less animal-derived greenhouse gas production.
Moreover, there is a preference for small ruminants, raised
non-intensively, or mono-gastric animals, which produce
less methane than beef(67). The large variety of fruits and
vegetables maintains biodiversity and promotes polyvalent
agriculture as part of sustainable and organic agriculture and
reduces contaminants. The recommendation for seasonal
local consumption is also a factor that favours energy
economy by reducing the need to heat greenhouses and the
need to transport produce from southern hemisphere
countries. Hence, adherence to a MD might help to develop
sustainable agriculture.
Concluding remarks
It is important to promote the MD in its entirety to include the
benefits of olive oil and to respect variety, diversity and other
aspects of the MD such as the structure of the meals and
their organisation through the day, and without snacking(68).
And to remember that it is more than just a diet, there is
also a Mediterranean lifestyle with physical activity – which
is mainly outdoors and good for vitamin D synthesis, and
also wine drunk in moderation with meals for gastronomy
and conviviality. Because a MD is good for individuals, for
public health, for health economics and for the environment,
Mediterranean countries should treasure it and should work
to promote it through information to the public and pro-
fessionals, and by spreading knowledge of food quality and
cooking practices. And, on a larger scale, this needs initiatives
from public health and agricultural policies.
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